Access considerations At the time of writing, the tablet is available privately, with NHS access dependent on a NICE appraisal
What the Research Says: In the landmark STEP 1 clinical trial, patients receiving 2.4 mg of semaglutide once weekly lost an average of 15% of their body weight over 68 weeks
Lee Rosebush, chairman of the industry group, said patient access to the medications "has taken an enormous step backwards." He said the FDA relied on data supplied by pharmaceutical companies to declare the GLP-1 medications are no longer in shortage, thus ending the legal avenue for compounders to sell less expensive copies
In extreme cases, kidney failure happens, which can be fatal
Additionally, freezing (below 0C) is equally damaging to the medication
Key Takeaways: Semaglutide and Fatigue Fatigue affects approximately 10% to 15% of people taking semaglutide Usually temporary, most common during first few weeks and dose increases Primarily caused by reduced calorie intake and rapid metabolic changes, not the medication directly Often improves within 2 to 4 weeks as your body adapts to each dose Manageable through proper nutrition, hydration, sleep, and activity strategies Persistent severe fatigue warrants medical evaluation Different from dangerous fatigue that signals medical problems Most people maintain normal energy levels throughout treatment Understanding Why Semaglutide Can Cause Tiredness Before jumping to solutions, understanding the mechanisms behind semaglutide-related fatigue helps you address the root causes effectively
